It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acute kidney injury (AKI) is prevalent and a leading cause of in-hospital death worldwide. Early prediction of AKI-related clinical events and timely intervention for high-risk patients could improve outcomes. We develop a deep learning model based on a nationwide multicenter cooperative network across China that includes 7,084,339 hospitalized patients, to dynamically predict the risk of in-hospital death (primary outcome) and dialysis (secondary outcome) for patients who developed AKI during hospitalization. A total of 137,084 eligible patients with AKI constitute the analysis set. In the derivation cohort, the area under the receiver operator curve (AUROC) for 24-h, 48-h, 72-h, and 7-day death are 95·05%, 94·23%, 93·53%, and 93·09%, respectively. For dialysis outcome, the AUROC of each time span are 88·32%, 83·31%, 83·20%, and 77·99%, respectively. The predictive performance is consistent in both internal and external validation cohorts. The model can predict important outcomes of patients with AKI, which could be helpful for the early management of AKI.
Early prediction of AKI-related clinical events and timely intervention for high-risk patients could improve outcomes. Here, the authors show a deep learning model that can identify patients with acute kidney injury (AKI) who are at high risk of death or dialysis at certain time points.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Electronic Science and Technology of China, Department of Nephrology and Nephrology Institute, Sichuan Provincial People’s Hospital, School of Medicine, Chengdu, China (GRID:grid.54549.39) (ISNI:0000 0004 0369 4060)
2 University of Electronic Science and Technology of China, Knowledge and Data Engineering Laboratory of Chinese Medicine, School of Information and Software Engineering, Chengdu, China (GRID:grid.54549.39) (ISNI:0000 0004 0369 4060)
3 Southern Medical University, National Clinical Research Center for Kidney Disease, State Laboratory of Organ Failure Research, Division of Nephrology, Nanfang Hospital, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471)
4 Southeast University School of Medicine, Institute of Nephrology, Zhongda Hospital, Nanjing, China (GRID:grid.263826.b) (ISNI:0000 0004 1761 0489)
5 Affiliated Hospital of Guangdong Medical University, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Zhanjiang, China (GRID:grid.410560.6) (ISNI:0000 0004 1760 3078)
6 Sun Yat-Sen University, Department of Nephrology, Sun Yat-Sen Memorial Hospital, Guangzhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X)
7 Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, China (GRID:grid.13402.34) (ISNI:0000 0004 1759 700X)
8 Huazhong University of Science and Technology, Division of Nephrology, Tongji Hospital, Tongji Medical College, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223)
9 University of Science and Technology of China, Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Hefei, China (GRID:grid.59053.3a) (ISNI:0000000121679639)
10 the First People’s Hospital of Foshan, Department of Nephrology, Foshan, China (GRID:grid.452881.2) (ISNI:0000 0004 0604 5998)
11 Shenzhen University, The Second People’s Hospital of Shenzhen, Shenzhen, China (GRID:grid.263488.3) (ISNI:0000 0001 0472 9649)
12 Guizhou University, Guizhou Provincial People’s Hospital, Guiyang, China (GRID:grid.443382.a) (ISNI:0000 0004 1804 268X)
13 Maoming People’s Hospital, Department of Critical Care Medicine, Maoming, China (GRID:grid.513391.c) (ISNI:0000 0004 8339 0314)
14 Children’s Hospital of Fudan University, Shanghai, China (GRID:grid.411333.7) (ISNI:0000 0004 0407 2968)
15 The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (GRID:grid.412465.0)
16 Sun Yat-Sen University, Huizhou Municipal Central Hospital, Huizhou, China (GRID:grid.12981.33) (ISNI:0000 0001 2360 039X)
17 Capital Medical University, Department of Nephrology, Beijing Tiantan Hospital, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X)
18 Guangzhou University of Chinese Medicine, Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685)
19 The Third Affiliated Hospital of Southern Medical University, Guangzhou, China (GRID:grid.413107.0)
20 Southern Medical University, Institute of Health Management, Guangzhou, China (GRID:grid.284723.8) (ISNI:0000 0000 8877 7471); DHC Technologies, Beijing, China (GRID:grid.284723.8)